title: Expression of inhibitors of apoptosis family protein in 7,12-dimethylbenz[a]anthracene-induced hamster buccal-pouch squamous-cell carcinogenesis is associated with mutant p53 accumulation and epigenetic changes.
abstract: Fifty outbred Syrian golden hamsters were equally divided into three experimental groups and two control groups. The pouches of the experimental groups were painted bilaterally with a 0.5% 7,12-dimethylbenz[a]anthracene (DMBA) solution thrice a week for 3, 7 and 14 weeks. One of the control groups was applied with mineral oil while another control group remained untreated throughout the experiment. Neither survivin nor cIAP2 could be detected in any of the control tissues, whereas survivin and cIAP2 were found to be significantly increased in 3-, 7- and 14-week DMBA-treated pouches compared with the control pouches. Expression of XIAP, cIAP1 and NAIP were noted for both the control and 3-, 7- and 14-week DMBA-treated pouches, but levels were found to be significantly elevated in the experimental groups compared with the control pouches. p53 was not detected in any control tissues, but was significantly increased in 3-, 7- and 14-week DMBA-treated pouches. Direct sequencing revealed a point mutation (C-->G) of p53 for pouch tissues treated with DMBA for 3 and 7 weeks, and there was a wide variation in the p53 sequence of the 14-week DMBA-treated pouch tissues, as compared with the control tissues. The control tissues had a survivin- and cIAP2-methylated allele, whereas the DMBA-treated tissues showed no evidence of survivin- and cIAP2-methylation. Neither the control nor DMBA-treated pouches showed evidence of XIAP-, cIAP1- or NAIP-methylation. Our results suggest that the expression of inhibitors of apoptosis family in DMBA-induced hamster buccal-pouch squamous-cell carcinogenesis may be modulated by both genetic (mutant p53) and epigenetic mechanisms.
authors.affiliation: Oral Pathology Department, School of Dentistry, Kaohsiung Medical University and Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
authors.forename: Shui-Sang
authors.initials: SS
authors.lastname: Hsue
authors.forename: Wen-Chen
authors.initials: WC
authors.lastname: Wang
authors.forename: Yuk-Kwan
authors.initials: YK
authors.lastname: Chen
authors.forename: Li-Min
authors.initials: LM
authors.lastname: Lin
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D017209:Apoptosis / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002610:Cheek; D006224:Cricetinae; D004252:DNA Mutational Analysis; D017931:DNA Primers / Q000235:genetics; D044127:Epigenesis, Genetic; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D016158:Genes, p53; D007150:Immunohistochemistry; D008297:Male; D008647:Mesocricetus; D008869:Microtubule-Associated Proteins / Q000235:genetics; D023421:Models, Animal; D009062:Mouth Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D017354:Point Mutation; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000032:analysis* / Q000235:genetics
chemical_list: D017931:DNA Primers; D008869:Microtubule-Associated Proteins; D051636:X-Linked Inhibitor of Apoptosis Protein; D015127:9,10-Dimethyl-1,2-benzanthracene